Cannabis Bioscience International Holdings, Inc. (CBIH) stock
CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31
$0.00+0.00 (+33.33%)
Close on Oct 19, 2026Market cap $2.33MP/E –Yield –
Cannabis Bioscience International operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cannabis Bioscience International's operating income for the twelve months ending Feb 28, 2026 was -$398.82K. For fiscal 2025 it was -$421.37K.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | May 31, 2025 | -$421.37K | – |
| FY2024 | May 31, 2024 | -$486.14K | – |
| FY2023 | May 31, 2023 | -$983.37K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -$93.26K | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -$95.88K | – |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$74.78K | – |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -$134.90K | – |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$129.23K | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -$59.63K | – |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -$97.60K | – |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -$29.63K | – |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$159.97K | – |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -$94.51K | – |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -$176.78K | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | -$274.90K | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -$284.87K | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -$183.61K | – |
See a number that looks wrong?